Insurers are urging the IRDAI to refine proposed commission caps and distribution rules, citing concerns over business viability. With the regulatory feedback period open until October 25, 2026, the potential reversal of the 2023 liberalization has created uncertainty for distributors and insurance stocks.
The Insurance Regulatory and Development Authority of India (IRDAI) has stirred significant debate following its September 2026 consultation paper, titled 'Recalibrating Economics of Insurance Distribution.' The regulator proposes to introduce tiered, product-specific commission caps and revise expense management limits for insurers. This proposal effectively seeks to reverse the 2023 liberalization, which had previously removed many commission restrictions to encourage competition.
Industry participants are pushing back against these proposed changes, arguing that a rigid, uniform cap on commissions may fail to recognize the operational differences between companies. Larger, established insurance firms typically benefit from extensive distribution networks and economies of scale. In contrast, smaller or newer companies often spend more to acquire customers and build a presence. Executives argue that imposing identical commission limits could make it financially difficult for smaller players to compete, potentially hindering their growth and ability to reach new customers.
Challenges in Health and Motor Segments
A central point of contention is the proposal to apply specific commission structures to different insurance products. The regulator has suggested first-year commission caps of 15% for distribution entities and 20% for agents in the health insurance segment, while motor third-party insurance faces significantly lower limits, effectively near zero for entities and 2.5% for agents. Industry representatives emphasize that health insurance requires substantial effort, including detailed underwriting, complex customer acquisition, and ongoing post-sales service. They argue that applying a flat percentage across the board does not reflect the actual complexity or cost of servicing these policies compared to the more straightforward motor insurance business.
Impact on Intermediaries and Market Sentiment
The uncertainty surrounding these potential rules has weighed on the stock market, particularly for listed insurance aggregators and financial intermediaries. Investors are assessing the risk of margin compression, as intermediaries may need to overhaul their revenue models if the final regulations significantly limit how much they can earn from selling insurance products. The proposed regulations also seek to address broader concerns regarding mis-selling and transparency, which the regulator aims to resolve by capping acquisition costs.
The Co-Payment Debate
Beyond commission caps, the industry is also reviewing a proposal to introduce a mandatory 10% co-payment for retail health insurance plans, capped at Rs 5 lakh. This measure is intended to lower premiums and discourage excessive claims. However, critics within the sector warn that this could reduce the appeal of comprehensive health insurance, especially for high-net-worth customers who may view the added out-of-pocket liability as a deterrent.
As the regulator continues to accept stakeholder feedback until October 25, 2026, the final framework remains a key monitorable. Investors are watching for any adjustments to the current draft, as the final implementation—potentially slated for 2027—will likely dictate the future profitability and distribution strategies for insurers and their partners across the country.